Rare Disease Trial, Recruiting (NCT05701787)

Rare Disease Trial, Recruiting NCT05701787 Sponsor: Shanghai Chest Hospital Condition: Rare Disease

Printed from Voxsanity (voxsanity.com.au) — NCT05701787 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Rare Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

"Who might be able to join this trial:

You have been diagnosed with a specific type of lung cancer called non-small cell lung cancer (NSCLC), confirmed by a laboratory test of tissue, and your cancer has one of a number of specific rare genetic changes (such as EGFR rare mutations, ALK fusion, ROS1 fusion, BRAF V600E, cMET exon 14 skipping, KRAS G12C, RET fusion, NTRK fusion, or similar) (confirm with trial site if unsure which mutations qualify).
You are 18 years of age or older.
You are able to understand the study information and are willing to sign a written consent form agreeing to take part.

Who may not be able to join:

There are no specific exclusion criteria listed for this trial (confirm with trial site, as additional requirements may apply in practice).

Important: Always verify eligibility with the trial site directly before applying."

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Xiaomin Niu, Shanghai Chest Hospital

Phone: 021-22200000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05701787

Sponsor: Shanghai Chest Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Rare Disease

Trial contact: 021-22200000

More information: https://clinicaltrials.gov/study/NCT05701787

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

"Who might be able to join this trial:

You have been diagnosed with a specific type of lung cancer called non-small cell lung cancer (NSCLC), confirmed by a laboratory test of tissue, and your cancer has one of a number of specific rare genetic changes (such as EGFR rare mutations, ALK fusion, ROS1 fusion, BRAF V600E, cMET exon 14 skipping, KRAS G12C, RET fusion, NTRK fusion, or similar) (confirm with trial site if unsure which mutations qualify).
You are 18 years of age or older.
You are able to understand the study information and are willing to sign a written consent form agreeing to take part.

Who may not be able to join:

There are no specific exclusion criteria listed for this trial (confirm with trial site, as additional requirements may apply in practice).

Important: Always verify eligibility with the trial site directly before applying."

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Shanghai Chest Hospital

Registry

ClinicalTrials.gov

Start date

1 January 2019

Est. completion

31 December 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Objective response rate (ORR); Disease control rate (DCR); Progression-free survival (PFS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov